{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:30:08Z","timestamp":1786509008303,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Although macrolide-resistant\n                      <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia prevalence exceeds 90% in the Republic of Korea, health insurance reimbursement policies historically restrict guideline-recommended tetracycline use in children aged &lt;12 years. After a post-pandemic outbreak, reimbursement coverage was expanded in late 2023, and clinical guidelines were updated in early 2024 to permit tetracycline use in this age group. This study evaluated the impact of these policy changes on nationwide pediatric prescribing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using national prescription and sentinel surveillance data (2015\u20132025), an interrupted time-series analysis assessed changes in tetracycline prescribing responsiveness to epidemic intensity, with the intervention point set to March 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Pediatric tetracycline prescribing remained low until 2023 but increased markedly in 2024, with annual standardized prescribing rates (units per 1000 population) rising from &lt;0.01 to 0.22, 0.01 to 0.74 and 0.91 to 1.74 in the 0\u20134, 5\u20139 and 10\u201314 year age groups, respectively. Before the intervention, prescribing showed no significant association with epidemic activity in any age group; after the intervention, significant synchronization emerged in children aged &lt;15 years (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Prescribing rates lagged the initial epidemic rise by approximately 2 months but declined in parallel as the outbreak resolved.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      After the 2024 policy changes, tetracycline prescriptions rose and fell in sync with\n                      <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia epidemic activity. This rapid de-escalation argues against persistent prescription drift and suggests active clinical judgment rather than passive exploitation of newly available access.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005356","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:00:26Z","timestamp":1786507226000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Changes in Pediatric Tetracycline Prescribing Patterns During the 2024 Mycoplasma pneumoniae Pneumonia Epidemic in the Republic of Korea"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-7645","authenticated-orcid":false,"given":"Seung Ha","family":"Song","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Seoul St. Mary\u2019s Hospital, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7145-8738","authenticated-orcid":false,"given":"Ye Kyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Bundang Hospital, Seoul National University, Seongnam, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3806-4275","authenticated-orcid":false,"given":"Bin","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seoul National University Boramae Medical Center, Seoul Metropolitan Government, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-7029","authenticated-orcid":false,"given":"Sujin","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Konkuk University Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1017-3274","authenticated-orcid":false,"given":"Young Joo","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hanil General Hospital, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-0715","authenticated-orcid":false,"given":"Young June","family":"Choe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-0951","authenticated-orcid":false,"given":"Youn Young","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"R1-20260812","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.3346\/jkms.2025.40.e5","article-title":"Etiology and clinical prediction of community-acquired lower respiratory tract Infection in children.","volume":"40","author":"Yoo","year":"2025","journal-title":"J Korean Med Sci"},{"key":"R2-20260812","doi-asserted-by":"crossref","first-page":"108093","DOI":"10.1016\/j.ijid.2025.108093","article-title":"Genomic surveillance for community-acquired pneumonia of unknown etiology in children.","volume":"161","author":"Kim","year":"2025","journal-title":"Int J Infect Dis"},{"key":"R3-20260812","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jinf.2008.02.018","article-title":"Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period.","volume":"56","author":"Eun","year":"2008","journal-title":"J Infect"},{"key":"R4-20260812","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3201\/eid1908.121455","article-title":"Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.","volume":"19","author":"Hong","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"R5-20260812","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3345\/kjp.2015.58.5.172","article-title":"Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years.","volume":"58","author":"Kim","year":"2015","journal-title":"Korean J Pediatr"},{"key":"R6-20260812","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","article-title":"Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.","volume":"16","author":"Lee","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R7-20260812","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.3346\/jkms.2025.40.e317","article-title":"Growing threat of macrolide-resistant Mycoplasma pneumoniae among children: what we know and what we need.","volume":"40","author":"Yun","year":"2025","journal-title":"J Korean Med Sci"},{"key":"R8-20260812","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia.","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20260812","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/INF.0000000000004568","article-title":"Treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a meta-analysis of macrolides versus tetracyclines.","volume":"44","author":"Bolormaa","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20260812","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1186\/s12879-021-06508-7","article-title":"Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.","volume":"21","author":"Ahn","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R11-20260812","doi-asserted-by":"crossref","first-page":"102589","DOI":"10.1016\/j.eclinm.2024.102589","article-title":"Effectiveness and safety of tetracyclines and quinolones in people with Mycoplasma pneumonia: a systematic review and network meta-analysis.","volume":"71","author":"Cai","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R12-20260812","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/INF.0000000000004995","article-title":"Trends in antibiotic use for pediatric patients with pneumonia: a nationwide analysis in South Korea (2016-2023).","volume":"45","author":"Park","year":"2026","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20260812","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research.","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"R22-20260812","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R24-20260812","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jpeds.2015.02.015","article-title":"No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever.","volume":"166","author":"Todd","year":"2015","journal-title":"J Pediatr"},{"key":"R25-20260812","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients\u2019 care.","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet"},{"key":"R26-20260812","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3947\/ic.2014.46.4.239","article-title":"Early additional immune-modulators for Mycoplasma pneumoniae pneumonia in children: an observation study.","volume":"46","author":"Youn","year":"2014","journal-title":"Infect Chemother"},{"key":"R27-20260812","doi-asserted-by":"crossref","first-page":"14860","DOI":"10.1038\/s41598-025-99537-0","article-title":"Treatment modalities for fever duration in children with Mycoplasma pneumoniae pneumonia.","volume":"15","author":"Kang","year":"2025","journal-title":"Sci Rep"},{"key":"R28-20260812","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.3346\/jkms.2025.40.e253","article-title":"Mycoplasma pneumoniae infections among children and adolescents in Korea, 2014-2024.","volume":"40","author":"Eun","year":"2025","journal-title":"J Korean Med Sci"},{"key":"R29-20260812","doi-asserted-by":"crossref","first-page":"e0100124","DOI":"10.1128\/spectrum.01001-24","article-title":"Trends in Mycoplasma pneumoniae infections in pediatric patient preceding, during, and following the COVID-19 pandemic: a comprehensive longitudinal analysis.","volume":"13","author":"Zhang","year":"2025","journal-title":"Microbiol Spectr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:00:28Z","timestamp":1786507228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005356","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}